Mirati Therapeutics, Inc.·4

Jan 24, 4:00 PM ET

Stelzer Laurie 4

4 · Mirati Therapeutics, Inc. · Filed Jan 24, 2023

Insider Transaction Report

Form 4
Period: 2023-01-20
Transactions
  • Award

    Common Stock

    2023-01-20+26,86484,662 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-20+45,45645,456 total
    Exercise: $45.66Exp: 2033-01-20Common Stock (45,456 underlying)
Footnotes (2)
  • [F1]This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date.
  • [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Documents

1 file
  • 4
    marketforms-58268.xmlPrimary

    PRIMARY DOCUMENT